EJI – Vol. 33 (4) 2026 – 02

Autophagy – related protein 5: A promising biomarker for disease activity and treatment response in lupus nephritis … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (4), October, 2026 Pages: 15–27....

EJI – Vol. 33 (4) 2026 – 01

Circulating regulatory B-cell subsets in type 2 diabetic nephropathy … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (4), October, 2026 Pages: 01–14. www.Ejimmunology.org https://doi.org/10.55133/eji.330401...

Vol. 33 (3) 2026 – 09

Evaluation of serum IL-6 and fecal calprotectin in covid-19 positive patients with GIT symptoms as markers of intestinal inflammation … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (3), July, 2026 Pages:...

Vol. 33 (3) 2026 – 08

Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33...

Vol. 33 (3) 2026 – 07

Evaluation of serum human galectin 3 as a marker of activity in inflammatory bowel disease in comparison to fecal calprotectin … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (3), July, 2026 Pages: 65–71....

Vol. 33 (3) 2026 – 06

Tumor necrosis factor alpha-induced protein3 rs;10499194 polymorphism enhances presepsin and sCD64 accuracy in differentiating infection from rheumatoid arthritis flare … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506)...